RU-486 Suspension and Review Act of 2003
Latest action · Nov 14, 2003 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedNov 6, 2003
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
RU-486 Suspension and Review Act of 2003 - Deems the approved application for the drug mifepristone (marketed as Mifeprex, commonly known as RU-486, and used for the chemically induced termination of intrauterine pregnancy) to have been suspended.
Directs the Comptroller General to review and report on the process by which the Food and Drug Administration (FDA) approved mifepristone. Provides for the contingent reinstatement of such drug if the report determines the approval to have been in accordance with the Federal Food, Drug, and Cosmetic Act.
Cosponsors 84
Members who signed on, in the order they did. Signatures ran from Nov 6, 2003 to Mar 16, 2004; 59 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MI | Bart Stupak | Original | Nov 6, 2003 |
| R-CO | Bob Beauprez | Original | Nov 6, 2003 |
| R-MS | Charles W. "Chip" Pickering | Original | Nov 6, 2003 |
| R-NJ | Christopher H. Smith | Original | Nov 6, 2003 |
| R-FL | Cliff Stearns | Original | Nov 6, 2003 |
| R-LA | David Vitter | Original | Nov 6, 2003 |
| R-IL | Donald A. Manzullo | Original | Nov 6, 2003 |
| R-CA | Duncan Hunter | Original | Nov 6, 2003 |
| R-VA | Edward L. Schrock | Original | Nov 6, 2003 |
| R-VA | Eric Cantor | Original | Nov 6, 2003 |
| R-OK | Ernest J. Istook Jr. | Original | Nov 6, 2003 |
| R-MN | Gil Gutknecht | Original | Nov 6, 2003 |
| R-SC | Henry E. Brown, Jr. | Original | Nov 6, 2003 |
| R-SC | J. Gresham Barrett | Original | Nov 6, 2003 |
| R-VA | J. Randy Forbes | Original | Nov 6, 2003 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Nov 6, 2003 |
| Health Subcommittee | Referred Nov 14, 2003 |
Actions 3
Everything that happened, newest first.
- Nov 14, 2003Referred to the Subcommittee on Health.
- Nov 6, 2003Introduced in House
- Nov 6, 2003Referred to the House Committee on Energy and Commerce.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1930 | RU-486 Suspension and Review Act of 2003 | Related bill | Nov 21, 2003 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug commonly known as RU-486 is deemed to have been withdrawn, to provide for the review by the Comptroller General of the United States of the process by which the Food and Drug Administration approved such drug, and for other purposes.
- Short Titles as Introduced
- RU-486 Suspension and Review Act of 2003
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Abortion
- Administrative procedure
- Commerce
- Congress
- Congressional investigations
- Congressional reporting requirements
- Congressional veto
- Department of Health and Human Services
- Drug approvals
- Drugs
- Food and Drug Administration (FDA)
- Government Operations and Politics
- Government publicity
- Health
- Labeling
- Law
Text 1
Each version as it was printed, newest first.
- Nov 6, 2003Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.